|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/205 | |
| C09K 3/30 | |||
| A61K 9/14 | |||
| A61K 9/00 |
| (11) | Number of the document | 2292584 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10176026.2 |
| Date of filing the European patent application | 2003-12-08 | |
| (97) | Date of publication of the European application | 2011-03-09 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 432195 P | 2002-12-10 | US |
| (72) |
McGlynn, Paul, US
Bakale, Roger, US
Sturge, Craig, CA
|
| (73) |
Sunovion Pharmaceuticals Inc.,
84 Waterford Drive, Marlborough, MA 01752,
US
|
| (54) | Pharmaceutical composition comprising Levalbuterol L-hemitartrate salt as aerosol formulation |
| Pharmaceutical composition comprising Levalbuterol L-hemitartrate salt as aerosol formulation |